glp-1 drugs and fatty liver Resolution of NASH hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis Why are GLP-1 agonists being
Description
This explainer will give you a brief overview of the issues and then summarize some recent publications the benefits and costs of drugs like semaglutide and tirzepatide

Moberly SP, Berwick ZC, Kohr M, Svendsen M, Mather KJ, Tune JD: Intracoronary glucagon-like peptide 1 preferentially augments glucose uptake in ischemic myocardium independent of changes in coronary flow

Diabetes Care 2013;36:29452951 [DOI] [PMC free article] [PubMed] [Google Scholar] 68.Wysham C, Blevins T, Arakaki R, et al

It naturally helps control blood sugar, slows the emptying of your stomach, and contributes to the sense of fullness you feel after a meal

9 Conclusion GLP-1RAs, a new type of diabetes medication, have shown great potential in treating liver diseases

The weekly injectable will be marketed under a new brand name, Yurpeak, leveraging Ciplas extensive distribution network to reach consumers beyond major cities
